- AI and pharma thought leaders to share insights on
transformative role of AI in drug discovery and development for
personalized medicine, rare diseases and more
NEW
YORK, June 24, 2024 /PRNewswire/ --
Cure.®, a healthcare innovation campus in New York City, and The New York Academy of
Sciences, an organization committed to advancing science and
technology for the benefit of society, today announced an exciting
two-part science technology seminar: Science and Business of
AI-Driven Drug Discovery and Deepfakes & Democracy in
the Age of AI.
Thought leaders in artificial intelligence and
biopharmaceuticals will share their insights on how AI and machine
learning accelerate target identification, predict compound
interactions, and optimize clinical trial designs. Attendees will
gain valuable perspectives on the potential for AI to drive
personalized medicine and tackle rare diseases, among other
potential applications.
Event Details for Science and Business of AI-Driven Drug
Discovery
- Date: Tuesday, June 25
- Time: 5:00 - 7:00 PM EDT
- Venue: Cure, 345 Park Avenue South, New York, NY
- Registration: Science and Business of AI-Driven Drug
Discovery Seminar
Speakers:
- Maria Luisa Pineda, PhD, Co-Founder and CEO of
Envisagenics
- Grant Mitchell, MD, MBA,
Co-Founder and CEO of Every Cure
- Andrea Califano, PhD, Chair, Department of Systems
Biology, Columbia University and
President, Chan Zuckerberg Biohub New York
Opening remarks will be made by Nicholas
B. Dirks, PhD, President and CEO, The New York Academy of
Sciences, and the seminar will be moderated by Seema Kumar, CEO of Cure.
"AI-driven drug discovery is poised to revolutionize the
biopharmaceutical industry by enhancing drug development
efficiency, accuracy, and cost-effectiveness," said Nicholas B. Dirks, President and CEO of The New
York Academy of Sciences. "These technological advancements
promise to bring more effective treatments to patients faster,
marking a significant milestone in modern medicine and public
health."
With only about 10 percent of drug candidates making it through
a typical development time of 12 to 18 years, the ability of AI and
ML tools to optimize discovery has become an area of intense
interest. The influx of substantial financial commitments from
private and public sectors drives new collaborations and
innovations.
"Our goal is to showcase real world examples from biotech and
life science leaders who are already using AI and ML tools to
develop new products, transform clinical trials, and work with
regulators," said Cure CEO Seema
Kumar. "They will share examples of how these tools are
changing the trajectory of healthcare research today and
transforming the landscape for a healthier tomorrow."
Information for Deepfakes & Democracy in the Age of
AI will be available soon.
About Cure.
Cure is a healthcare innovation campus in
the heart of New York City that
features laboratory and business facilities, a collaboration
residency, office space and premium event venues, including an
education center, conference center, and iconic rooftop facility,
as well as tools, mentoring, networking, and other assistance to
members of its ecosystem. Cure houses on-campus startups and
established companies. Residents regularly create synergies and
collaborative partnerships with peer organizations across the
spectrum of healthcare, from academic or private to non-profit or
government, and focus on diagnostic, device, drug or vaccine
discovery, development and production as well as care delivery and
public health. Cure also offers industry-leading event programming
focused on critical health topics. Cure's mission is to foster and
accelerate advances in health. For more information, please visit
wewillcure.com.
About The New York Academy of Sciences
The New York
Academy of Sciences is an independent, not-for-profit organization
that since 1817 has been committed to advancing science for the
benefit of society. With more than 20,000 Members in 100 countries,
the Academy advances scientific and technical knowledge, addresses
global challenges with science-based solutions, and sponsors a wide
variety of educational initiatives at all levels for STEM and
STEM-related fields. The Academy hosts programs and publishes
content in the life and physical sciences, the social sciences,
nutrition, artificial intelligence, computer science, and
sustainability. The Academy also provides professional and
educational resources for researchers across all phases of their
careers. Please visit us online at www.nyas.org.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cure-and-the-new-york-academy-of-sciences-to-co-host-forum-on-science-and-business-of-ai-driven-drug-discovery-302180739.html
SOURCE Cure